Arpino G - Search Results

1

Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.

Buonaiuto R, Neola G, Cecere SC, Caltavituro A, Cefaliello A, Pietroluongo E, De Placido P, Giuliano M, Arpino G, De Angelis C. Buonaiuto R, et al. Among authors: arpino g. Biomolecules. 2023 Apr 5;13(4):653. doi: 10.3390/biom13040653. Biomolecules. 2023. PMID: 37189400 Free PMC article. Review.

2

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.

Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, Elledge RM. Arpino G, et al. Clin Cancer Res. 2004 Sep 1;10(17):5670-6. doi: 10.1158/1078-0432.CCR-04-0110. Clin Cancer Res. 2004. PMID: 15355892

3

Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.

Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM. Arpino G, et al. Cancer. 2002 Apr 15;94(8):2119-27. doi: 10.1002/cncr.10455. Cancer. 2002. PMID: 12001107 Free article. Review.

4

Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

Arpino G, Weiss HL, Clark GM, Hilsenbeck SG, Osborne CK. Arpino G, et al. J Clin Oncol. 2005 Jul 20;23(21):4687-94. doi: 10.1200/JCO.2005.04.076. Epub 2005 Apr 18. J Clin Oncol. 2005. PMID: 15837971

5

Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts.

Rimawi MF, Wiechmann LS, Wang YC, Huang C, Migliaccio I, Wu MF, Gutierrez C, Hilsenbeck SG, Arpino G, Massarweh S, Ward R, Soliz R, Osborne CK, Schiff R. Rimawi MF, et al. Among authors: arpino g. Clin Cancer Res. 2011 Mar 15;17(6):1351-61. doi: 10.1158/1078-0432.CCR-10-1905. Epub 2010 Dec 7. Clin Cancer Res. 2011. PMID: 21138857 Free PMC article.

6

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM. Arpino G, et al. Breast Cancer Res. 2004;6(3):R149-56. doi: 10.1186/bcr767. Epub 2004 Feb 17. Breast Cancer Res. 2004. PMID: 15084238 Free PMC article.

7

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM. Arpino G, et al. Ann Intern Med. 2005 Sep 20;143(6):446-57. doi: 10.7326/0003-4819-143-6-200509200-00009. Ann Intern Med. 2005. PMID: 16172443

8

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study.

Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E. Lazzaro C, et al. Among authors: arpino g. Clinicoecon Outcomes Res. 2013 Apr 11;5:125-35. doi: 10.2147/CEOR.S41850. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23610525 Free PMC article.

9

Lobular neoplasia on core-needle biopsy--clinical significance.

Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Arpino G, et al. Cancer. 2004 Jul 15;101(2):242-50. doi: 10.1002/cncr.20318. Cancer. 2004. PMID: 15241819 Free article.

10

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM. Arpino G, et al. J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61. doi: 10.1093/jnci/dji249. J Natl Cancer Inst. 2005. PMID: 16145046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters